Abstract
Patients presenting emergently with proliferative diabetic retinopathy have low rates of follow-up compliance, 61.9%. This trend is consistent across nearly all demographic variables. The specific insurance payer, length of visit, and interval to follow-up were found to have a significant impact on follow-up compliance and should help identify high risk patients.